933 results on '"Jhingran, Anuja"'
Search Results
102. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study
103. Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study
104. Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression
105. O019/#977 Short course adjuvant vaginal cuff brachytherapy in early endometrial cancer: adverse events and early patient reported outcomes
106. EP366/#354 The IGCS virtual tumor board in Vietnam: an impact assessment of the last 5 years
107. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas
108. PO29 Presentation Time: 7:40 AM
109. Saturday, June 18, 20222:00 PM - 3:00 PM PL01 Presentation Time: 2:00 PM
110. GPP06 Presentation Time: 8:50 AM
111. GPP03 Presentation Time: 8:20 AM
112. 674 IMMUNOCERV, an ongoing phase II trial combining PDS0101, an HPV-specific T cell immunotherapy, with chemotherapy and radiation for treatment of locally advanced cervical cancers
113. GPP05 Presentation Time: 8:40 AM
114. Neoplasms of the Cervix
115. Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer
116. Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer
117. GSOR09 Presentation Time: 5:40 PM: AI Based Sentiment Analysis of Online Discussions Related to Cervical Brachytherapy
118. GPP04 Presentation Time: 9:27 AM: The Role of an Enhanced Recovery after Surgery (ERAS) Protocol for Patients with Cervical Cancer Undergoing Definitive Chemoradiation with Brachytherapy Boost
119. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma
120. Uterine Sarcomas
121. Treatment of Locally Advanced Cervical Cancer
122. Treatment of Endometrial Cancer
123. 66: Do Anthropometric Indices Correlate with Prostate Cancer in Nigerian Men?
124. 164: Interruption of Care: An Important Quality Metric in Chemo-Radiation for Locally Advanced Head and Neck Squamous Cell Cancers (LASCCHN) in Sub-Saharan Africa
125. Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques
126. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix
127. Involved-field radiation therapy for locoregionally recurrent ovarian cancer
128. Intensity modulated radiotherapy in gynecologic cancers: Hope, hype or hyperbole?
129. Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer
130. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I–IIIA (1988) uterine papillary serous carcinoma of the endometrium
131. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer
132. Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer
133. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer
134. Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer
135. 180 Efficacy of online pelvic malignancy contouring training in low- to middle-income Asian countries
136. Cervical Cancer: A Global Health Crisis
137. A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0418
138. Pelvic Normal Tissue Contouring Guidelines for Radiation Therapy: A Radiation Therapy Oncology Group Consensus Panel Atlas
139. Role of Definitive Radiation Therapy in Carcinoma of Unknown Primary in the Abdomen and Pelvis
140. ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer
141. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: Low-dose-rate and pulsed-dose-rate brachytherapy
142. Vaginal Motion and Bladder and Rectal Volumes During Pelvic Intensity-Modulated Radiation Therapy After Hysterectomy
143. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors
144. Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study
145. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal
146. Automatic contouring QA method using a deep learning–based autocontouring system
147. Cancer-associated Lactobacillus iners are genetically distinct and associated with chemoradiation resistance in cervical cancer
148. Additional file 1 of Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure
149. 31 - Malignant diseases of the cervix: Microinvasive and Invasive Carcinoma: Diagnosis and Management
150. 28 - Principles of radiation therapy and chemotherapy in gynecologic cancer: Basic Principles, Uses, and Complications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.